Warning Labels on Cigarillo Packages for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to examine how different warning labels on cigarillo packages influence users' smoking habits and intentions. Participants will join one of three groups, each exposed to different types of warnings: pictorial images, FDA text-only warnings, or Surgeon General text-only warnings. Over four weeks, the study involves sorting cigarillo packages into flavor categories. The trial seeks current cigarillo users who smoke at least once a week. As an unphased trial, it offers participants the chance to contribute to significant research that may impact public health policies on smoking.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe?
Research shows that picture warnings on tobacco products, such as cigarillos, are generally accepted by users. Studies have found that these warnings can increase the likelihood of wanting to quit smoking and lead to more frequent quit attempts. No evidence suggests that viewing these images causes any health problems.
Text-only warnings from the FDA or Surgeon General are also common on tobacco products and have not been known to cause harm. They aim to inform users about the dangers of smoking.
In summary, these warnings, whether pictorial or text-based, are designed to encourage quitting without harming the viewer.12345Why are researchers excited about this trial?
Researchers are excited about these warning labels on cigarillo packages because they offer a fresh approach to discouraging smoking. Unlike traditional text-only warnings, pictorial warnings use vivid images to convey the dangers of smoking, potentially making a stronger impact on consumers. The study also explores the effectiveness of different types of text-only warnings, comparing those from the FDA and the Surgeon General, which may provide insights into which messages resonate most with smokers. This trial could lead to more effective packaging strategies that better communicate health risks and encourage smoking cessation.
What evidence suggests that this trial's warning labels could be effective for reducing cigarillo smoking?
Research shows that picture warnings on cigarillo packages can be very effective. Participants in the pictorial warnings arm of this trial will view these types of warnings. A study that analyzed various research found that picture warnings outperformed text-only warnings in 12 out of 17 measures. Additionally, picture warnings tend to capture attention more effectively and increase the desire to quit smoking. In one study, similar picture warnings on cigarette packages led to a 4% drop in smoking rates in the first year. These findings suggest that picture warnings might provoke stronger reactions and encourage quitting more than text-only warnings, which participants in the FDA text-only warnings and Surgeon General text-only warnings arms will view.12346
Who Is on the Research Team?
Jennifer Ross, PhD
Principal Investigator
School of Public Health - Health Law Policy & Management Dept
Are You a Good Fit for This Trial?
This study is for current cigarillo smokers who have used cigarillos at least once a week in the past month. Participants will be recruited through Qualtrics Research Services.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants participate in an image-sorting task for 4 weeks, sorting cigarillo packages into flavor categories
Follow-up
Participants are monitored for changes in intentions and behaviors related to cigarillo smoking
What Are the Treatments Tested in This Trial?
Interventions
- Package image sorting with FDA text-only warnings
- Package image sorting with pictorial warnings
- Package image sorting with Surgeon General text-only warnings
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
Brown University
Collaborator
National Cancer Institute (NCI)
Collaborator